Independent reference · Facts sourced from CPSC, ENERGY STAR and DOE Record verified Aug 18, 2026
ItemRecalls.com
Active recall — stop using this product now.
Remedy: full refund · About 21,400 units
Recall No. 21-089 Published February 25, 2021

Imatinib Mesylate Tablets 100 mg, Imatinib Mesylate Tablets 400 mg, Pregabalin Capsules 50 mg, Pregabalin Capsules 75 mg, Pregabalin Capsules 100 mg, Pregabalin Capsules 150 mg, Sevelamer Carbonate Tablets 800 mg, Tadalafil Tablets 5 mg and Tadalafil Tabl

The products are prescription medications that were labeled and distributed by Dr. Reddy's for institutional use only. The prescription medications were distributed by third party wholesalers to retail pharmacies and could have been dispensed to consumers. The packaging of the products is not child resistant and can pose a risk of poisoning if the contents are swallowed by young children. Manufactured by Dr. Reddy's Laboratories and sold at Beginning in 2018, Dr. Reddy's sold the recalled medications to wholesalers. Ultimately, these medications could have been sold to consumers at retail pharmacies in the United States at prices varying based on quantities prescribed, health insurance terms.

View the official CPSC notice Watch this model Jump to the remedy
Recalled Dr. Reddy's Imatinib Mesylate Tablets 100 mg
What you are looking at

Recalled Dr. Reddy's Imatinib Mesylate Tablets 100 mg

Image: CPSC recall notice Two more views

Check the label first

Compare every letter, number, space and suffix. A similar-looking product with a different suffix may not be part of this recall.

Affected model numbers

Why it was recalled

The products are prescription medications that were labeled and distributed by Dr. Reddy's for institutional use only. The prescription medications were distributed by third party wholesalers to retail pharmacies and could have been dispensed to consumers. The packaging of the products is not child resistant and can pose a risk of poisoning if the contents are swallowed by young children.

0
Incident reports to the firm
1
Injuries reported
0
SaferProducts.gov reports

No incidents or injuries have been reported.

The official remedy

Remedy type: refund
01
What to do

Consumers should immediately store the recalled medications in a safe location out of reach of children and contact Dr. Reddy's for a full refund.

Product and sales details

ManufacturerDr. Reddy's Laboratories, Ltd., of India
UnitsAbout 21,400
Made inIndia
Sold atBeginning in 2018, Dr. Reddy's sold the recalled medications to wholesalers. Ultimately, these medications could have been sold to consumers at retail pharmacies in the United States at prices varying based on quantities prescribed, health insurance terms

How to reach the firm

Phone
888-375-3784
8 a.m. to 8 p.m. ET Monday through Friday
Recall page
www.drreddys.com

Verify phone numbers, hours and web addresses on the current CPSC notice before contacting the firm.